BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35244686)

  • 1. B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; Casabonne D; Cerhan JR; Cozen W; Alarcón G; Martínez-Maza O; Brown EE; Bracci PM; Turner J; Hjalgrim H; Bhatti P; Zhang Y; Birmann BM; Flowers CR; Paltiel O; Holly EA; Kane E; Weisenburger DD; Maynadié M; Cocco P; Foretova L; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zheng T; Skibola CF; Clavel J; Monnereau A; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1103-1110. PubMed ID: 35244686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
    Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcón GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
    Am J Epidemiol; 2015 Mar; 181(6):406-21. PubMed ID: 25713336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
    Kleinstern G; Camp NJ; Berndt SI; Birmann BM; Nieters A; Bracci PM; McKay JD; Ghesquières H; Lan Q; Hjalgrim H; Benavente Y; Monnereau A; Wang SS; Zhang Y; Purdue MP; Zeleniuch-Jacquotte A; Giles GG; Vermeulen R; Cocco P; Albanes D; Teras LR; Brooks-Wilson AR; Vajdic CM; Kane E; Caporaso NE; Smedby KE; Salles G; Vijai J; Chanock SJ; Skibola CF; Rothman N; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1074-1078. PubMed ID: 32108027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
    Chang CM; Wang SS; Dave BJ; Jain S; Vasef MA; Weisenburger DD; Cozen W; Davis S; Severson RK; Lynch CF; Rothman N; Cerhan JR; Hartge P; Morton LM
    Int J Cancer; 2011 Aug; 129(4):938-47. PubMed ID: 20949561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insecticide use and risk of non-Hodgkin lymphoma subtypes: A subset meta-analysis of the North American Pooled Project.
    Kachuri L; Beane Freeman LE; Spinelli JJ; Blair A; Pahwa M; Koutros S; Hoar Zahm S; Cantor KP; Weisenburger DD; Pahwa P; Dosman JA; McLaughlin JR; Demers PA; Harris SA
    Int J Cancer; 2020 Dec; 147(12):3370-3383. PubMed ID: 32574374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.
    't Mannetje A; De Roos AJ; Boffetta P; Vermeulen R; Benke G; Fritschi L; Brennan P; Foretova L; Maynadié M; Becker N; Nieters A; Staines A; Campagna M; Chiu B; Clavel J; de Sanjose S; Hartge P; Holly EA; Bracci P; Linet MS; Monnereau A; Orsi L; Purdue MP; Rothman N; Lan Q; Kane E; Costantini AS; Miligi L; Spinelli JJ; Zheng T; Cocco P; Kricker A
    Environ Health Perspect; 2016 Apr; 124(4):396-405. PubMed ID: 26340796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
    Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
    Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
    Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
    Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
    Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
    Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").
    Engels EA; Parsons R; Besson C; Morton LM; Enewold L; Ricker W; Yanik EL; Arem H; Austin AA; Pfeiffer RM
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1105-13. PubMed ID: 27197296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
    Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
    Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
    Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
    Ekström Smedby K; Vajdic CM; Falster M; Engels EA; Martínez-Maza O; Turner J; Hjalgrim H; Vineis P; Seniori Costantini A; Bracci PM; Holly EA; Willett E; Spinelli JJ; La Vecchia C; Zheng T; Becker N; De Sanjosé S; Chiu BC; Dal Maso L; Cocco P; Maynadié M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Grulich AE; Cozen W
    Blood; 2008 Apr; 111(8):4029-38. PubMed ID: 18263783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study.
    Mildon KH; Ansell P; Roman E; Kane EV
    Cancer Causes Control; 2010 Dec; 21(12):2079-83. PubMed ID: 20697798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies.
    Kane EV; Bernstein L; Bracci PM; Cerhan JR; Costas L; Dal Maso L; Holly EA; La Vecchia C; Matsuo K; Sanjose S; Spinelli JJ; Wang SS; Zhang Y; Zheng T; Roman E; Kricker A;
    Ann Oncol; 2013 Feb; 24(2):433-441. PubMed ID: 22967995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BC; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami HO; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):130-44. PubMed ID: 25174034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically Determined Height and Risk of Non-hodgkin Lymphoma.
    Moore A; Kane E; Wang Z; Panagiotou OA; Teras LR; Monnereau A; Wong Doo N; Machiela MJ; Skibola CF; Slager SL; Salles G; Camp NJ; Bracci PM; Nieters A; Vermeulen RCH; Vijai J; Smedby KE; Zhang Y; Vajdic CM; Cozen W; Spinelli JJ; Hjalgrim H; Giles GG; Link BK; Clavel J; Arslan AA; Purdue MP; Tinker LF; Albanes D; Ferri GM; Habermann TM; Adami HO; Becker N; Benavente Y; Bisanzi S; Boffetta P; Brennan P; Brooks-Wilson AR; Canzian F; Conde L; Cox DG; Curtin K; Foretova L; Gapstur SM; Ghesquières H; Glenn M; Glimelius B; Jackson RD; Lan Q; Liebow M; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Morton LM; North KE; Offit K; Padoan M; Patel AV; Piro S; Ravichandran V; Riboli E; de Sanjose S; Severson RK; Southey MC; Staines A; Stewart C; Travis RC; Weiderpass E; Weinstein S; Zheng T; Chanock SJ; Chatterjee N; Rothman N; Birmann BM; Cerhan JR; Berndt SI
    Front Oncol; 2019; 9():1539. PubMed ID: 32064237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
    Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
    Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.